The first trial in the mass tort had been scheduled to begin Monday, but most of the program’s cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.
March 11, 2024 at 12:45 PM
3 minute read
Litigation Reporter
Philadelphia’s coordinated litigation over bladder medication Elmiron is wrapping up.
The first trial in the mass tort had been scheduled to begin Monday, but most of the program’s cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Elmiron 100mg pills by Janssen Pharmaceuticals Inc. Credit: NIH via Wikimedia Commons
Tobi Millrood, with Kline & Specter. Courtesy photo
